Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grover P Miller

Showing results (41-50 of 65) with videos related to

Pageof 7
Sort By:
Drug Metabolism Reviews|June 8, 2019
Biotransformation and bioactivation reactions - 2018 literature highlightsS Cyrus Khojasteh, Namandjé N Bumpus, James P Driscoll, et al.
Drug Metabolism Reviews|July 10, 2020
Novel advances in biotransformation and bioactivation research-2019 year in review<sup>.</sup>S Cyrus Khojasteh, James P Driscoll, Klarissa D Jackson, et al.
Biochemical Pharmacology|August 5, 2018
Lamisil (terbinafine) toxicity: Determining pathways to bioactivation through computational and experimental approachesDustyn A Barnette, Mary A Davis, Na L Dang, et al.
Archives of Biochemistry and Biophysics|December 3, 2014
Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolitesC Preston Pugh, Dakota L Pouncey, Jessica H Hartman, et al.
Chemical Research in Toxicology|May 5, 2009
Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humansGrover P Miller, Drew R Jones, Shane Z Sullivan, et al.
Drug Metabolism Letters|January 22, 2013
Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarinsSo-Young Kim, Ji-Yeon Kang, Jessica H Hartman, et al.
Molecules (Basel, Switzerland)|October 23, 2020
Significance of Competing Metabolic Pathways for 5F-APINACA Based on Quantitative KineticsAnna O Pinson, Dakota L Pouncey, Mary A Schleiff, et al.
Frontiers in Pharmacology|January 31, 2022
Discovery of Novel Reductive Elimination Pathway for 10-HydroxywarfarinDakota L Pouncey, Dustyn A Barnette, Riley W Sinnott, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 30, 2008
Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarinGrover P Miller, Cheryl F Lichti, Agnieszka K Zielinska, et al.
Chemical Research in Toxicology|December 15, 2015
Kynurenine Signaling Increases DNA Polymerase Kappa Expression and Promotes Genomic Instability in Glioblastoma CellsApril C L Bostian, Leena Maddukuri, Megan R Reed, et al.
Pageof 7

Showing results (41-50 of 65) with videos related to

Sort By:
Pageof 7
Drug Metabolism Reviews|June 8, 2019
Biotransformation and bioactivation reactions - 2018 literature highlightsS Cyrus Khojasteh, Namandjé N Bumpus, James P Driscoll, et al.
Drug Metabolism Reviews|July 10, 2020
Novel advances in biotransformation and bioactivation research-2019 year in review<sup>.</sup>S Cyrus Khojasteh, James P Driscoll, Klarissa D Jackson, et al.
Biochemical Pharmacology|August 5, 2018
Lamisil (terbinafine) toxicity: Determining pathways to bioactivation through computational and experimental approachesDustyn A Barnette, Mary A Davis, Na L Dang, et al.
Archives of Biochemistry and Biophysics|December 3, 2014
Multiple UDP-glucuronosyltransferases in human liver microsomes glucuronidate both R- and S-7-hydroxywarfarin into two metabolitesC Preston Pugh, Dakota L Pouncey, Jessica H Hartman, et al.
Chemical Research in Toxicology|May 5, 2009
Assessing cytochrome P450 and UDP-glucuronosyltransferase contributions to warfarin metabolism in humansGrover P Miller, Drew R Jones, Shane Z Sullivan, et al.
Drug Metabolism Letters|January 22, 2013
Metabolism of R- and S-warfarin by CYP2C19 into four hydroxywarfarinsSo-Young Kim, Ji-Yeon Kang, Jessica H Hartman, et al.
Molecules (Basel, Switzerland)|October 23, 2020
Significance of Competing Metabolic Pathways for 5F-APINACA Based on Quantitative KineticsAnna O Pinson, Dakota L Pouncey, Mary A Schleiff, et al.
Frontiers in Pharmacology|January 31, 2022
Discovery of Novel Reductive Elimination Pathway for 10-HydroxywarfarinDakota L Pouncey, Dustyn A Barnette, Riley W Sinnott, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 30, 2008
Identification of hydroxywarfarin binding site in human UDP glucuronosyltransferase 1a10: phenylalanine90 is crucial for the glucuronidation of 6- and 7-hydroxywarfarin but not 8-hydroxywarfarinGrover P Miller, Cheryl F Lichti, Agnieszka K Zielinska, et al.
Chemical Research in Toxicology|December 15, 2015
Kynurenine Signaling Increases DNA Polymerase Kappa Expression and Promotes Genomic Instability in Glioblastoma CellsApril C L Bostian, Leena Maddukuri, Megan R Reed, et al.
Pageof 7